OBJECTIVE: Although elevated plasma concentrations of serum amyloid A (SAA) are associated strongly with increased risk for atherosclerotic cardiovascular disease in humans, the role of SAA in the pathogenesis of lesion formation remains obscure. Our goal was to determine the impact of SAA deficiency on atherosclerosis in hypercholesterolemic mice. APPROACH AND RESULTS: Apolipoprotein E-deficient (apoE(-/-)) mice, either wild type or deficient in both major acute phase SAA isoforms, SAA1.1 and SAA2.1, were fed a normal rodent diet for 50 weeks. Female mice, but not male apoE-/- mice deficient in SAA1.1 and SAA2.1, had a modest increase (22%; P≤0.05) in plasma cholesterol concentrations and a 53% increase in adipose mass compared with apoE-/- mice expressing SAA1.1 and SAA2.1 that did not affect the plasma cytokine levels or the expression of adipose tissue inflammatory markers. SAA deficiency did not affect lipoprotein cholesterol distributions or plasma triglyceride concentrations in either male or female mice. Atherosclerotic lesion areas measured on the intimal surfaces of the arch, thoracic, and abdominal regions were not significantly different between apoE-/- mice deficient in SAA1.1 and SAA2.1 and apoE-/- mice expressing SAA1.1 and SAA2.1 in either sex. To accelerate lesion formation, mice were fed a Western diet for 12 weeks. SAA deficiency had effect neither on diet-induced alterations in plasma cholesterol, triglyceride, or cytokine concentrations nor on aortic atherosclerotic lesion areas in either male or female mice. In addition, SAA deficiency in male mice had no effect on lesion areas or macrophage accumulation in the aortic roots. CONCLUSIONS: The absence of endogenous SAA1.1 and 2.1 does not affect atherosclerotic lipid deposition in apolipoprotein E-deficient mice fed either normal or Western diets.
OBJECTIVE: Although elevated plasma concentrations of serum amyloid A (SAA) are associated strongly with increased risk for atherosclerotic cardiovascular disease in humans, the role of SAA in the pathogenesis of lesion formation remains obscure. Our goal was to determine the impact of SAA deficiency on atherosclerosis in hypercholesterolemicmice. APPROACH AND RESULTS:Apolipoprotein E-deficient (apoE(-/-)) mice, either wild type or deficient in both major acute phase SAA isoforms, SAA1.1 and SAA2.1, were fed a normal rodent diet for 50 weeks. Female mice, but not male apoE-/- mice deficient in SAA1.1 and SAA2.1, had a modest increase (22%; P≤0.05) in plasma cholesterol concentrations and a 53% increase in adipose mass compared with apoE-/- mice expressing SAA1.1 and SAA2.1 that did not affect the plasma cytokine levels or the expression of adipose tissue inflammatory markers. SAA deficiency did not affect lipoprotein cholesterol distributions or plasma triglyceride concentrations in either male or female mice. Atherosclerotic lesion areas measured on the intimal surfaces of the arch, thoracic, and abdominal regions were not significantly different between apoE-/- mice deficient in SAA1.1 and SAA2.1 and apoE-/- mice expressing SAA1.1 and SAA2.1 in either sex. To accelerate lesion formation, mice were fed a Western diet for 12 weeks. SAA deficiency had effect neither on diet-induced alterations in plasma cholesterol, triglyceride, or cytokine concentrations nor on aortic atherosclerotic lesion areas in either male or female mice. In addition, SAA deficiency in male mice had no effect on lesion areas or macrophage accumulation in the aortic roots. CONCLUSIONS: The absence of endogenous SAA1.1 and 2.1 does not affect atheroscleroticlipid deposition in apolipoprotein E-deficient mice fed either normal or Western diets.
Authors: Willibald Maier; Lukas A Altwegg; Roberto Corti; Steffen Gay; Martin Hersberger; Friedrich E Maly; Gabor Sütsch; Marco Roffi; Michel Neidhart; Franz R Eberli; Felix C Tanner; Sharon Gobbi; Arnold von Eckardstein; Thomas F Lüscher Journal: Circulation Date: 2005-03-07 Impact factor: 29.690
Authors: Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Nancy R Webb; Frederick C de Beer Journal: Cytokine Date: 2012-11-17 Impact factor: 3.861
Authors: Katherine E Lewis; Elizabeth A Kirk; Thomas O McDonald; Shari Wang; Thomas N Wight; Kevin D O'Brien; Alan Chait Journal: Circulation Date: 2004-07-26 Impact factor: 29.690
Authors: Maria C de Beer; Joanne M Wroblewski; Victoria P Noffsinger; Ailing Ji; Jason M Meyer; Deneys R van der Westhuyzen; Frederick C de Beer; Nancy R Webb Journal: J Lipids Date: 2013-01-30
Authors: Tomáš Vaisar; Chongren Tang; Ilona Babenko; Patrick Hutchins; Jake Wimberger; Anthony F Suffredini; Jay W Heinecke Journal: J Lipid Res Date: 2015-05-20 Impact factor: 5.922
Authors: Joel C Thompson; Patricia G Wilson; Preetha Shridas; Ailing Ji; Maria de Beer; Frederick C de Beer; Nancy R Webb; Lisa R Tannock Journal: Atherosclerosis Date: 2017-11-17 Impact factor: 5.162
Authors: Nancy R Webb; Maria C De Beer; Joanne M Wroblewski; Ailing Ji; William Bailey; Preetha Shridas; Richard J Charnigo; Victoria P Noffsinger; Jassir Witta; Deborah A Howatt; Anju Balakrishnan; Debra L Rateri; Alan Daugherty; Frederick C De Beer Journal: Arterioscler Thromb Vasc Biol Date: 2015-03-05 Impact factor: 8.311
Authors: Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen Journal: J Lipid Res Date: 2016-03-27 Impact factor: 5.922
Authors: Patricia G Wilson; Joel C Thompson; Preetha Shridas; Patrick J McNamara; Maria C de Beer; Frederick C de Beer; Nancy R Webb; Lisa R Tannock Journal: Arterioscler Thromb Vasc Biol Date: 2018-08 Impact factor: 8.311
Authors: Joel C Thompson; Colton Jayne; Jennifer Thompson; Patricia G Wilson; Meghan H Yoder; Nancy Webb; Lisa R Tannock Journal: J Lipid Res Date: 2014-11-26 Impact factor: 5.922
Authors: Edson M de Oliveira; Thais P Ascar; Jacqueline C Silva; Silvana Sandri; Silene Migliorini; Ricardo A Fock; Ana Campa Journal: Diabetologia Date: 2016-04-28 Impact factor: 10.122